Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Status: Not yet enrolling

Conditions: ImmuNe-Mediated Inflammatory Diseases

Treatments: Other: Questionnaires

Study type: Observational

Funder types: Other

Identifiers

NCT05172284

REMIND

Details and patient eligibility

About

Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies. This aim is achieved by evaluating the achievement of PASI 50 and PASI 75 scores at week 16 from the start of treatment.

Enrollment: 2,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with a diagnosis of IMID.
• Patients of any age, including minors.
• Patients treated with approved medications for the condition in question and/or phototherapy.
• Patients who agree to sign informed consent.

Exclusion criteria

• Patients without a diagnosis of IMID.
• Patients who do not consent to sign informed consent.

Trial design

2,000 participants in 12 patient groups

Psoriasis

Treatment:

Other: Questionnaires

Psoriatic arthritis

Treatment:

Other: Questionnaires

Atopic dermatitis

Treatment:

Other: Questionnaires

Chronic urticaria

Treatment:

Other: Questionnaires

Suppurative hydrosadenitis

Treatment:

Other: Questionnaires

Systemic lupus erythematosus

Treatment:

Other: Questionnaires

Acne vulgaris

Treatment:

Other: Questionnaires

Rosacea

Treatment:

Other: Questionnaires

Seborrheic dermatitis

Treatment:

Other: Questionnaires

Contact dermatitis

Treatment:

Other: Questionnaires

Chronic eczema of the hands

Treatment:

Other: Questionnaires

Vitiligo

Treatment:

Other: Questionnaires